Novavax Inc. Stock Underperforms Friday When Compared To Competitors
I'm PortAI, I can summarize articles.
Novavax Inc. (NVAX) shares fell 1.79% to $6.57 on Friday, underperforming compared to competitors like Johnson & Johnson, Pfizer, and Merck, which saw gains. This marked the second consecutive day of losses for Novavax, with the stock closing 43.12% below its 52-week high. Trading volume was 2.9 million, below the 50-day average of 4.1 million. The NASDAQ Composite and Dow Jones Industrial Average also fell during the session.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments